The year 2020-21 has been nothing short of a roller coaster ride for each of us. At onemoment we are spiraling towards the ground at uncontrollable speed owing to thechallenges posed by the pandemic and soon after we are making a steady climb upwardspropelled by our resilience to never back down in the face of adversity. Over the pastyear with every incumbent wave we have outmaneuvered the pandemic. We have progressed onmaking India safe on the back of the robust healthcare interventions put in place by theGovernment private institutions pharmaceutical companies healthcare professionals andother frontline warriors. I urge you all to join me in applauding my peers in theIndustry Government officials healthcare practitioners trade partners Municipalauthorities and frontline warriors for their unparalleled commitment to saving lives andgearing our country towards a healthier and happier future.
With at least 13 different vaccines being administered globally1 againstCOVID-19 what better time than now to realize the importance of SCIENCE. Undoubtedlydeveloping and delivering the world's first COVID-19 vaccine is one of Pfizer's biggeststories today but we have a history of breakthroughs that have impacted lives of millionsand billions of people world over. Today we celebrate each of those breakthroughs!
More recently while the world grappled with the repercussions of the pandemic wecontinued to work towards accomplishing our purpose Breakthroughs that Change Patients'Lives and implemented various innovations to make sure that despite lockdowns andtravel restrictions our medicines and vaccines reached over 240 million patients acrossIndia. We accelerated launches of life-saving products initiated our digitaltransformation journey and contributed to India's COVID-19 relief efforts. However ashas been our belief since day one 71 years ago our journey to impact patients' lives hasonly just begun and there's much more that we wish to achieve to make a difference in thelives of patients and communities alike.
On the business front while the industry grew at 4.3% your Company delivered 6.4%growth for the year (IQVIA MAT Mar 21). Our flagship brands such as Becosules MucaineCorex Gelusil Eliquis and Zavicefta showed strong performance throughout the year. Tofurther accelerate our growth we have proactively taken several steps towards our productportfolio resource allocation and go-to-market strategies that are expected to yieldpositive results in the coming years.
A new innovative Pfizer
As we turned the leaf to 2021 Pfizer Inc. launched a new corporate brand identity.This transformation was our way of expressing Pfizer's renewed focus on science andpatients a charter that is the blueprint of our growth in the future. Our dynamic newlogo birthed from the new identity is a symbol of scientific innovation. To craft thisnew logo we unlocked the pill form to reveal the core of what we do - the DNA helix thecode and engine of human potential.
Every successful emblem captures its company's DNA embracing its history while leaninginto its future. Pfizer's new corporate brand identity is a digital-first expression ofits commitment to the transformative power of science. It's a dynamic reflection of ourpurpose. And it's a clear signal that the new Pfizer is about daring more courageouslyinquiring more deeply and advocating more passionately to make what was once unimaginable reality.
Tackling the COVID crisis
2020-21 seemed to be the year of COVID-19 but we made it a year of excellence andempathy. Our manufacturing units continued to churn essential medicines and ourcolleagues at these locations braved all odds to fulfill their commitment to protectingpeople's lives. Our Supply Chain colleagues collaborated with equally dedicated partnersfrom within the industry and beyond to ensure that our medicines reached hospitalsclinics and pharmacies. Our actions were driven by the belief embedded in our hearts andminds that everyone has the right to good health.
Our organisation is centered around people and their health needs. Hence caring forthe community has been an integral part of our way of doing business. Since the first wavehit our shores we have rolled up our sleeves and supported the Government in shoulderingthe responsibility of making India safe again. From donating masks ventilators medicalequipment essential drugs RT-PCR test kits and much more to those in need to helpingmake 400 beds operational equipped with Oxygen cylinders for COVID patients being treatedat the Yamuna COVID Centre in Delhi. Our Global counterparts too extended a helping handto pull India out of suffering through one of the most enormous humanitarian reliefefforts amassed by our organisation ever in any country.
I have always been mesmerised by the capabilities that humankind possesses - ourability to come together behind a cause and see to it that it achieves success. Thepandemic reminded me of this ability of ours again. While it showed us the worst ofnature we witnessed the best of humanity.
Building our human capital
While there is a circle of life that exists - one that hangs in a delicate balance toensure that all living beings thrive there's a similar harmony that orchestrates betweenorganisations and colleagues. To maintain this harmony provide a brighter future forPfizer and an excellent quality of life for our colleagues we have always focused onattracting the right talent and equipping them with the right tools to succeed. Over thepast year we have focused on making your Company as diverse as the patients andcommunities we serve. To this end in addition to onboarding talent from diversebackgrounds we have relooked at our policies to ensure an outstanding work-life balanceprovide adequate support to colleagues and make moments that matter to them morememorable.
All this and more has led to Pfizer being certified as a Great Place to Workby the Great Place to work Institute. This certification is the Gold Standard' thatorganisations around the globe aspire to achieve to enhance and endorse their employerbrand. It reflects our High Trust
High-Performance Culture that each of our colleague has been instrumental in building.
Our field colleagues mastered digital platforms to continue their relationships withhealthcare professionals; we launched innovative platforms and engagement activities tomeet patients' needs. We also transformed many of our internal systems to make them agileand go hand-in-glove with the requirements of our trade partners and meet the demands ofthe digital age. Today and in the years to come our commitment to science and patientswill be fulfilled by the coming together of the genius of our colleagues and thebrilliance of the latest developments in technology.
We at Pfizer if it results in a better life for our patients. The year
2020-21 has witnessed our efforts to achieve just that and make the impossiblepossible. Continuing with the same momentum on our journey we wish to make more therapiesaccessible to patients and physicians across India. While we play our parts to the best ofour abilities to all pharma industry members I request you to rally behind ourcollective aim and make a difference in people's lives. Let us all collaborate discussinnovative ideas and make
India stand out with its achievements in healthcare. To our shareholders I thank youfor your belief in Pfizer and what it stands for.